Cardiac Monitoring & Cardiac Rhythm Management Devices Market Worth USD 30 billion by 2030 - Exclusive Report by Growth Plus Reports

NEW YORK, June 29, 2022 /PRNewswire/ -- The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to clock US$ ~30 billion by 2030 owing to increasing awareness among the patients regarding early diagnosis & monitoring of CVDs. Cardiac monitoring devices are used to monitor heartbeat, assess the presence and severity of cardiac disease in patients, and evaluate the efficiency of drugs, interventions, and device implants. Cardiac rhythm management device includes implantable devices, leads, and accessories, as well as external devices to treat and manage arrhythmia-related diseases either too slow a heart rhythm (pacemakers) or too fast a rhythm (cardioverter-defibrillators) thereby helping patients to improve their overall health status.

Download PDF Brochure: https://growthplusreports.com/inquiry/request-sample/cardiac-monitoring-&-cardiac-rhythm-management-devices-market/7625

The global cardiac monitoring & cardiac rhythm management devices market has been analyzed from four different perspectives – Devices for Cardiac Monitoring, Devices for Cardiac Rhythm Management, End User, and Region.

Market Driver

According to a paper published in the Journal of the American College of Cardiology that examined the total magnitude of CVD burden and trends over 30 years worldwide, the number of people dying from cardiovascular disease (CVD) is steadily increasing, including one-third of all deaths globally in 2019.

The statistics highlight the urgent need for nations to set up public health initiatives that are both affordable and focused on lowering cardiovascular risk through modifiable behaviours. The leading cause of death worldwide, CVD—particularly ischemic heart disease and stroke—plays a significant role in disability and rising health care expenses. While the number of CVD deaths climbed consistently from 12.1 million in 1990 to 18.6 million in 2019, the prevalence of all CVD cases nearly doubled from 271 million to 523 million. Ischemic heart disease and stroke accounted for the majority of CVD fatalities worldwide in 2019, growing significantly since 1990. While YLDs doubled from 17.7 in 1990 to 34.4 million in 2019, the global trends for DALYs and YLLs also climbed dramatically. Hence the growing prevalence of cardiovascular diseases globally, is directly driving the demand for basic to advanced cardiac monitoring and cardiac rhythm management devices.

Excerpts from 'By Device Segmentation'

The global cardiac monitoring & cardiac rhythm management, the market has been segmented into pacemakers and defibrillators. Pacemakers are further bifurcated - by implantability [implantable pacemakers and external pacemakers] and by type [dual-chamber pacemakers, single-chamber pacemakers, and biventricular/CRT pacemakers].

Whereas, defibrillators are further categorized into implantable cardioverter defibrillators (ICD) [S-ICD and T-ICD] and external defibrillators [manual external defibrillator, automatic external defibrillator, and wearable cardioverter defibrillator]. In this segment, defibrillators are leading the market with technological advancement, precision, and sensitivity for cardiac disease diagnosis and treatment.  For instance, in November 2021, Vektor Medical received FDA clearance for vMAP: the first technology designed to identify arrhythmia anywhere in the heart within minutes by using ECG data. This technology does not require vests, CT or MRI imaging, or invasive mapping.

Request Sample Pages: https://growthplusreports.com/inquiry/request-sample/cardiac-monitoring-&-cardiac-rhythm-management-devices-market/7625

Excerpts from 'By End User Segmentation'

The global cardiac monitoring & cardiac rhythm management devices market has been segmented majorly into three distinct categories depending on end user, viz. hospitals, clinics & cardiac specialty centers; home care settings; and ambulatory care centers.

The hospitals, clinics & cardiac specialty centers segment holds the largest share in the market in the cardiac monitoring & cardiac rhythm management devices market. The cardiac monitoring & cardiac rhythm management devices belong to the category of critical disease management which requires quick attention from hospital care and medical experts. Also, the growth of the segment can mainly be attributed to the growing number of patients visiting hospitals for prediagnosis of heart conditions, the increasing number of cardiac implantation procedures and rising adoption of cardiac monitoring devices in hospitals during the pandemic.

Excerpts from 'By Region Segmentation'

The global cardiac monitoring & cardiac rhythm management devices market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share in the global cardiac monitoring & cardiac rhythm management devices market, Factors such as the growing prevalence of cardiovascular diseases in the region are increasing geriatric population, developed infrastructure, rapid adoption of technologically advanced products and growing awareness among the patients can be attributed for the large share of the region in the global market. After North America, Asia Pacific Countries such as India, China, and Japan in the APAC region, are projected to offer significant growth opportunities owing to the increasing prevalence of cardiovascular diseases and rising geriatric population in the region, followed by Europe & Rest of the World (RoW).

Excerpts from 'Competitive Landscape'

The prominent players operating in the global cardiac monitoring & cardiac rhythm management devices market are:

• General Electric Company
• Abbott Laboratories Inc
• Boston Scientific Corporation
• Koninklijke Philips N.V
• Medtronic PLC
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd
• Schiller
• Biotronik
• BPL Medical Technologies
• Nihon Kohden Corporation
• Among others

Table of Contents

1. INTRODUCTION
1. Market Ecosystem
2. Geographic Scope
3. Timeline Under Consideration
1. Historical Years – 2018 & 2019
2. Base Year – 2020
3. Forecasted Years – 2021 to 2030
4. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Their Competitive Positioning (2020)
4. MARKET DYNAMICS
1. Drivers
2. Restraints/Challenges
3. Opportunities
5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET – ANALYSIS & FORECAST, BY DEVICES FOR CARDIAC MONITORING
1. Electrocardiogram (ECG) Devices
1. Resting ECG
2. Stress ECG
3. Holter Monitors
2. Implantable Loop Recorders (ILR)
3. Cardiac Output Monitoring (COM) Devices
1. Minimally Invasive COM Devices
2. Noninvasive COM Devices
4. Mobile Cardiac Telemetry Monitoring (MCT/MCOT)
5. Event Monitors

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Purchase this premium report now: https://growthplusreports.com/checkout?_token=vlEoVvQoqlf0ZuRybx15NBl6Zi8v7RTSeRRzhnyi&report_id=7625&license=Single&submit=

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: [email protected] 
Phone no: +91 96545 76783
Web: https://growthplusreports.com/ 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports